 | • レポートコード：20QY06-08525 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、免疫チェックポイント阻害剤のグローバル市場について種類別（CTLA4、PD1、その他）、用途別（医療、実験、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・免疫チェックポイント阻害剤市場の概要 ・世界の主要地域別免疫チェックポイント阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の免疫チェックポイント阻害剤市場規模2015-2026：種類別（CTLA4、PD1、その他） ・世界の免疫チェックポイント阻害剤市場規模2015-2026：用途別（医療、実験、その他） ・免疫チェックポイント阻害剤の北米市場規模2015-2020 ・免疫チェックポイント阻害剤のヨーロッパ市場規模2015-2020 ・免疫チェックポイント阻害剤の中国市場規模2015-2020 ・免疫チェックポイント阻害剤の日本市場規模2015-2020 ・免疫チェックポイント阻害剤の東南アジア市場規模2015-2020 ・免疫チェックポイント阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Advaxis、Agenus、Amgen、Bristol Myers Squibb、Faron Pharmaceuticals、Genentech、Genocea、Incyte Corporation、Innate Pharma、Kite Pharma、MacroGenics、Merck、NewLink Genetics Corp、Sorrento Therapeutics、TG Therapeutics） ・免疫チェックポイント阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・免疫チェックポイント阻害剤の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Immune Check Point Inhibitor Market
The global Immune Check Point Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Immune Check Point Inhibitor Scope and Market Size
The global Immune Check Point Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immune Check Point Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immune Check Point Inhibitor market is segmented into
CTLA 4
PD 1
Others
Segment by Application, the Immune Check Point Inhibitor market is segmented into
Medical Care
Experiment
Others
The Immune Check Point Inhibitor market is analysed and market size information is provided by regions (countries). Segment by Application, the Immune Check Point Inhibitor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immune Check Point Inhibitor Market Share Analysis
Immune Check Point Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immune Check Point Inhibitor business, the date to enter into the Immune Check Point Inhibitor market, Immune Check Point Inhibitor product introduction, recent developments, etc.
The major vendors covered:
Advaxis
Agenus
Amgen
Bristol Myers Squibb
Faron Pharmaceuticals
Genentech
Genocea
Incyte Corporation
Innate Pharma
Kite Pharma
MacroGenics
Merck
NewLink Genetics Corp
Sorrento Therapeutics
TG Therapeutics
Table of Contents
1 Immune Check Point Inhibitor Market Overview
1.1 Immune Check Point Inhibitor Product Scope
1.2 Immune Check Point Inhibitor Segment by Type
1.2.1 Global Immune Check Point Inhibitor Sales by Type (2020-2026)
1.2.2 CTLA 4
1.2.3 PD 1
1.2.4 Others
1.3 Immune Check Point Inhibitor Segment by Application
1.3.1 Global Immune Check Point Inhibitor Sales Comparison by Application (2020-2026)
1.3.2 Medical Care
1.3.3 Experiment
1.3.4 Others
1.4 Immune Check Point Inhibitor Market Estimates and Forecasts (2015-2026)
1.4.1 Global Immune Check Point Inhibitor Sales Growth Rate (2015-2026)
1.4.2 Global Immune Check Point Inhibitor Revenue and Growth Rate (2015-2026)
1.4.3 Global Immune Check Point Inhibitor Price Trends (2015-2026)
2 Immune Check Point Inhibitor Estimate and Forecast by Region
2.1 Global Immune Check Point Inhibitor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Immune Check Point Inhibitor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Immune Check Point Inhibitor Sales Market Share by Region (2015-2020)
2.2.2 Global Immune Check Point Inhibitor Revenue Market Share by Region (2015-2020)
2.3 Global Immune Check Point Inhibitor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Immune Check Point Inhibitor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Immune Check Point Inhibitor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Immune Check Point Inhibitor Estimates and Projections (2015-2026)
2.4.2 Europe Immune Check Point Inhibitor Estimates and Projections (2015-2026)
2.4.3 China Immune Check Point Inhibitor Estimates and Projections (2015-2026)
2.4.4 Japan Immune Check Point Inhibitor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Immune Check Point Inhibitor Estimates and Projections (2015-2026)
2.4.6 India Immune Check Point Inhibitor Estimates and Projections (2015-2026)
3 Global Immune Check Point Inhibitor Competition Landscape by Players
3.1 Global Top Immune Check Point Inhibitor Players by Sales (2015-2020)
3.2 Global Top Immune Check Point Inhibitor Players by Revenue (2015-2020)
3.3 Global Immune Check Point Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Check Point Inhibitor as of 2019)
3.4 Global Immune Check Point Inhibitor Average Price by Company (2015-2020)
3.5 Manufacturers Immune Check Point Inhibitor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Immune Check Point Inhibitor Players (Opinion Leaders)
4 Global Immune Check Point Inhibitor Market Size by Type
4.1 Global Immune Check Point Inhibitor Historic Market Review by Type (2015-2020)
4.1.1 Global Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
4.1.2 Global Immune Check Point Inhibitor Revenue Market Share by Type (2015-2020)
4.1.3 Global Immune Check Point Inhibitor Price by Type (2014-2020)
4.2 Global Immune Check Point Inhibitor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Immune Check Point Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Immune Check Point Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Global Immune Check Point Inhibitor Price Forecast by Type (2021-2026)
5 Global Immune Check Point Inhibitor Market Size by Application
5.1 Global Immune Check Point Inhibitor Historic Market Review by Application (2015-2020)
5.1.1 Global Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
5.1.2 Global Immune Check Point Inhibitor Revenue Market Share by Application (2015-2020)
5.1.3 Global Immune Check Point Inhibitor Price by Application (2015-2020)
5.2 Global Immune Check Point Inhibitor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Immune Check Point Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Immune Check Point Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Immune Check Point Inhibitor Price Forecast by Application (2021-2026)
3 North America Immune Check Point Inhibitor Market Facts & Figures
3.2 North America Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
3.3 North America Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
3.4 North America Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
4 Europe Immune Check Point Inhibitor Market Facts & Figures
4.2 Europe Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
4.3 Europe Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
4.4 Europe Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
5 China Immune Check Point Inhibitor Market Facts & Figures
5.2 China Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
5.3 China Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
5.4 China Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
6 Japan Immune Check Point Inhibitor Market Facts & Figures
6.2 Japan Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
6.3 Japan Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
6.4 Japan Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
7 Southeast Asia Immune Check Point Inhibitor Market Facts & Figures
7.2 Southeast Asia Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
8 India Immune Check Point Inhibitor Market Facts & Figures
8.2 India Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
8.3 India Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
8.4 India Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Immune Check Point Inhibitor Business
12.1 Advaxis
12.1.1 Advaxis Immune Check Point Inhibitor Corporation Information
12.1.2 Advaxis Immune Check Point Inhibitor Business Overview and Total Revenue
12.1.3 Advaxis Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Advaxis Immune Check Point Inhibitor Products Offered
12.1.5 Advaxis Recent Development
12.2 Agenus
12.2.1 Agenus Immune Check Point Inhibitor Corporation Information
12.2.2 Agenus Immune Check Point Inhibitor Business Overview and Total Revenue
12.2.3 Agenus Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Agenus Immune Check Point Inhibitor Products Offered
12.2.5 Agenus Recent Development
12.3 Amgen
12.3.1 Amgen Immune Check Point Inhibitor Corporation Information
12.3.2 Amgen Immune Check Point Inhibitor Business Overview and Total Revenue
12.3.3 Amgen Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Amgen Immune Check Point Inhibitor Products Offered
12.3.5 Amgen Recent Development
12.4 Bristol Myers Squibb
12.4.1 Bristol Myers Squibb Immune Check Point Inhibitor Corporation Information
12.4.2 Bristol Myers Squibb Immune Check Point Inhibitor Business Overview and Total Revenue
12.4.3 Bristol Myers Squibb Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol Myers Squibb Immune Check Point Inhibitor Products Offered
12.4.5 Bristol Myers Squibb Recent Development
12.5 Faron Pharmaceuticals
12.5.1 Faron Pharmaceuticals Immune Check Point Inhibitor Corporation Information
12.5.2 Faron Pharmaceuticals Immune Check Point Inhibitor Business Overview and Total Revenue
12.5.3 Faron Pharmaceuticals Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Faron Pharmaceuticals Immune Check Point Inhibitor Products Offered
12.5.5 Faron Pharmaceuticals Recent Development
12.6 Genentech
12.6.1 Genentech Immune Check Point Inhibitor Corporation Information
12.6.2 Genentech Immune Check Point Inhibitor Business Overview and Total Revenue
12.6.3 Genentech Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Genentech Immune Check Point Inhibitor Products Offered
12.6.5 Genentech Recent Development
12.7 Genocea
12.7.1 Genocea Immune Check Point Inhibitor Corporation Information
12.7.2 Genocea Immune Check Point Inhibitor Business Overview and Total Revenue
12.7.3 Genocea Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Genocea Immune Check Point Inhibitor Products Offered
12.7.5 Genocea Recent Development
12.8 Incyte Corporation
12.8.1 Incyte Corporation Immune Check Point Inhibitor Corporation Information
12.8.2 Incyte Corporation Immune Check Point Inhibitor Business Overview and Total Revenue
12.8.3 Incyte Corporation Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Incyte Corporation Immune Check Point Inhibitor Products Offered
12.8.5 Incyte Corporation Recent Development
12.9 Innate Pharma
12.9.1 Innate Pharma Immune Check Point Inhibitor Corporation Information
12.9.2 Innate Pharma Immune Check Point Inhibitor Business Overview and Total Revenue
12.9.3 Innate Pharma Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Innate Pharma Immune Check Point Inhibitor Products Offered
12.9.5 Innate Pharma Recent Development
12.10 Kite Pharma
12.10.1 Kite Pharma Immune Check Point Inhibitor Corporation Information
12.10.2 Kite Pharma Immune Check Point Inhibitor Business Overview and Total Revenue
12.10.3 Kite Pharma Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Kite Pharma Immune Check Point Inhibitor Products Offered
12.10.5 Kite Pharma Recent Development
12.11 MacroGenics
12.11.1 MacroGenics Immune Check Point Inhibitor Corporation Information
12.11.2 MacroGenics Immune Check Point Inhibitor Business Overview and Total Revenue
12.11.3 MacroGenics Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.11.4 MacroGenics Immune Check Point Inhibitor Products Offered
12.11.5 MacroGenics Recent Development
12.12 Merck
12.12.1 Merck Immune Check Point Inhibitor Corporation Information
12.12.2 Merck Immune Check Point Inhibitor Business Overview and Total Revenue
12.12.3 Merck Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Merck Immune Check Point Inhibitor Products Offered
12.12.5 Merck Recent Development
12.13 NewLink Genetics Corp
12.13.1 NewLink Genetics Corp Immune Check Point Inhibitor Corporation Information
12.13.2 NewLink Genetics Corp Immune Check Point Inhibitor Business Overview and Total Revenue
12.13.3 NewLink Genetics Corp Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.13.4 NewLink Genetics Corp Immune Check Point Inhibitor Products Offered
12.13.5 NewLink Genetics Corp Recent Development
12.14 Sorrento Therapeutics
12.14.1 Sorrento Therapeutics Immune Check Point Inhibitor Corporation Information
12.14.2 Sorrento Therapeutics Immune Check Point Inhibitor Business Overview and Total Revenue
12.14.3 Sorrento Therapeutics Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Sorrento Therapeutics Immune Check Point Inhibitor Products Offered
12.14.5 Sorrento Therapeutics Recent Development
12.15 TG Therapeutics
12.15.1 TG Therapeutics Immune Check Point Inhibitor Corporation Information
12.15.2 TG Therapeutics Immune Check Point Inhibitor Business Overview and Total Revenue
12.15.3 TG Therapeutics Immune Check Point Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.15.4 TG Therapeutics Immune Check Point Inhibitor Products Offered
12.15.5 TG Therapeutics Recent Development
13 Immune Check Point Inhibitor Manufacturing Cost Analysis
13.1 Immune Check Point Inhibitor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Immune Check Point Inhibitor
13.4 Immune Check Point Inhibitor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Immune Check Point Inhibitor Distributors List
14.3 Immune Check Point Inhibitor Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Immune Check Point Inhibitor Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Immune Check Point Inhibitor Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Immune Check Point Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Immune Check Point Inhibitor Sales (K Pcs) by Region (2015-2020)
Table 5. Global Immune Check Point Inhibitor Sales Market Share by Region (2015-2020)
Table 6. Global Immune Check Point Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Immune Check Point Inhibitor Revenue Share by Region (2015-2020)
Table 8. Global Immune Check Point Inhibitor Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Immune Check Point Inhibitor Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Immune Check Point Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Immune Check Point Inhibitor Revenue Share Forecast by Region (2021-2026)
Table 12. Global Immune Check Point Inhibitor (K Pcs) of Key Companies (2015-2020)
Table 13. Global Immune Check Point Inhibitor Sales Share by Company (2015-2020)
Table 14. Global Immune Check Point Inhibitor Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Immune Check Point Inhibitor Revenue Share by Company (2015-2020)
Table 16. Global Immune Check Point Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Check Point Inhibitor as of 2019)
Table 17. Global Immune Check Point Inhibitor Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Immune Check Point Inhibitor Manufacturing Sites and Area Served
Table 19. Manufacturers Immune Check Point Inhibitor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Immune Check Point Inhibitor Players
Table 22. Global Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 23. Global Immune Check Point Inhibitor Sales Share by Type (2015-2020)
Table 24. Global Immune Check Point Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Immune Check Point Inhibitor Price (K Pcs) by Type (2015-2020)
Table 26. Global Immune Check Point Inhibitor Sales Share by Type (2021-2026)
Table 27. Global Immune Check Point Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Immune Check Point Inhibitor Revenue Share by Type (2021-2026)
Table 29. Global Immune Check Point Inhibitor Price (K Pcs) by Type (2021-2026)
Table 30. Global Immune Check Point Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 31. Global Immune Check Point Inhibitor Sales Share by Application (2015-2020)
Table 32. Global Immune Check Point Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Immune Check Point Inhibitor Price (K Pcs) by Application (2015-2020)
Table 34. Global Immune Check Point Inhibitor Sales (K Pcs) by Application (2021-2026)
Table 35. Global Immune Check Point Inhibitor Sales Share by Application (2021-2026)
Table 36. Global Immune Check Point Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Immune Check Point Inhibitor Revenue Share by Application (2021-2026)
Table 38. Global Immune Check Point Inhibitor Price (K Pcs) by Application (2021-2026)
Table 39. United States Immune Check Point Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 40. United States Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
Table 41. United States Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 42. United States Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 43. United States Immune Check Point Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 44. United States Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Europe Immune Check Point Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
Table 47. Europe Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 49. Europe Immune Check Point Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 51. China Immune Check Point Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 52. China Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
Table 53. China Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 54. China Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 55. China Immune Check Point Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 56. China Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
Table 57. Japan Immune Check Point Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
Table 59. Japan Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 61. Japan Immune Check Point Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Immune Check Point Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
Table 69. India Immune Check Point Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 70. India Immune Check Point Inhibitor Sales Market Share by Company (2015-2020)
Table 71. India Immune Check Point Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 72. India Immune Check Point Inhibitor Sales Market Share by Type (2015-2020)
Table 73. India Immune Check Point Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 74. India Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
Table 75. Advaxis Corporation Information
Table 76. Advaxis Description and Business Overview
Table 77. Advaxis Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Advaxis Immune Check Point Inhibitor Product
Table 79. Advaxis Recent Development
Table 80. Agenus Corporation Information
Table 81. Agenus Description and Business Overview
Table 82. Agenus Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Agenus Immune Check Point Inhibitor Product
Table 84. Agenus Recent Development
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Amgen Immune Check Point Inhibitor Product
Table 89. Amgen Recent Development
Table 90. Bristol Myers Squibb Corporation Information
Table 91. Bristol Myers Squibb Description and Business Overview
Table 92. Bristol Myers Squibb Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Bristol Myers Squibb Immune Check Point Inhibitor Product
Table 94. Bristol Myers Squibb Recent Development
Table 95. Faron Pharmaceuticals Corporation Information
Table 96. Faron Pharmaceuticals Description and Business Overview
Table 97. Faron Pharmaceuticals Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Faron Pharmaceuticals Immune Check Point Inhibitor Product
Table 99. Faron Pharmaceuticals Recent Development
Table 100. Genentech Corporation Information
Table 101. Genentech Description and Business Overview
Table 102. Genentech Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Genentech Immune Check Point Inhibitor Product
Table 104. Genentech Recent Development
Table 105. Genocea Corporation Information
Table 106. Genocea Description and Business Overview
Table 107. Genocea Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Genocea Immune Check Point Inhibitor Product
Table 109. Genocea Recent Development
Table 110. Incyte Corporation Corporation Information
Table 111. Incyte Corporation Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Incyte Corporation Description and Business Overview
Table 113. Incyte Corporation Immune Check Point Inhibitor Product
Table 114. Incyte Corporation Recent Development
Table 115. Innate Pharma Corporation Information
Table 116. Innate Pharma Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Innate Pharma Description and Business Overview
Table 118. Innate Pharma Immune Check Point Inhibitor Product
Table 119. Innate Pharma Recent Development
Table 120. Kite Pharma Corporation Information
Table 121. Kite Pharma Description and Business Overview
Table 122. Kite Pharma Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Kite Pharma Immune Check Point Inhibitor Product
Table 124. Kite Pharma Recent Development
Table 125. MacroGenics Corporation Information
Table 126. MacroGenics Description and Business Overview
Table 127. MacroGenics Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. MacroGenics Immune Check Point Inhibitor Product
Table 129. MacroGenics Recent Development
Table 130. Merck Corporation Information
Table 131. Merck Description and Business Overview
Table 132. Merck Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Merck Immune Check Point Inhibitor Product
Table 134. Merck Recent Development
Table 135. NewLink Genetics Corp Corporation Information
Table 136. NewLink Genetics Corp Description and Business Overview
Table 137. NewLink Genetics Corp Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. NewLink Genetics Corp Immune Check Point Inhibitor Product
Table 139. NewLink Genetics Corp Recent Development
Table 140. Sorrento Therapeutics Corporation Information
Table 141. Sorrento Therapeutics Description and Business Overview
Table 142. Sorrento Therapeutics Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Sorrento Therapeutics Immune Check Point Inhibitor Product
Table 144. Sorrento Therapeutics Recent Development
Table 145. TG Therapeutics Corporation Information
Table 146. TG Therapeutics Description and Business Overview
Table 147. TG Therapeutics Immune Check Point Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. TG Therapeutics Immune Check Point Inhibitor Product
Table 149. TG Therapeutics Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Immune Check Point Inhibitor Distributors List
Table 153. Immune Check Point Inhibitor Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Check Point Inhibitor Product Picture
Figure 2. Global Immune Check Point Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Immune Check Point Inhibitor Market Share by Application in 2020 & 2026
Figure 6. Medical Care Examples
Figure 7. Experiment Examples
Figure 8. Others Examples
Figure 9. Global Immune Check Point Inhibitor Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Immune Check Point Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Immune Check Point Inhibitor Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Immune Check Point Inhibitor Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Immune Check Point Inhibitor Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Immune Check Point Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Immune Check Point Inhibitor Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Immune Check Point Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Immune Check Point Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Immune Check Point Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Immune Check Point Inhibitor Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Immune Check Point Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Immune Check Point Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Immune Check Point Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Immune Check Point Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Immune Check Point Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Immune Check Point Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Immune Check Point Inhibitor Players Market Share by Revenue in Immune Check Point Inhibitor 2015 & 2019
Figure 27. Immune Check Point Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Immune Check Point Inhibitor Revenue Share by Type (2015-2020)
Figure 29. Global Immune Check Point Inhibitor Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Immune Check Point Inhibitor Revenue Share by Application (2015-2020)
Figure 31. Global Immune Check Point Inhibitor Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 33. United States Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 34. Europe Immune Check Point Inhibitor Sales Market Share by Company in 2019
Figure 35. Europe Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 36. Europe Immune Check Point Inhibitor Sales Market Share by Application in 2019
Figure 37. China Immune Check Point Inhibitor Sales Market Share by Company in 2019
Figure 38. China Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 39. China Immune Check Point Inhibitor Sales Market Share by Application in 2019
Figure 40. Japan Immune Check Point Inhibitor Sales Market Share by Company in 2019
Figure 41. Japan Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 42. Japan Immune Check Point Inhibitor Sales Market Share by Application in 2019
Figure 43. Southeast Asia Immune Check Point Inhibitor Sales Market Share by Company in 2019
Figure 44. Southeast Asia Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 45. Southeast Asia Immune Check Point Inhibitor Sales Market Share by Application in 2019
Figure 46. India Immune Check Point Inhibitor Sales Market Share by Company in 2019
Figure 47. India Immune Check Point Inhibitor Sales Market Share by Type in 2019
Figure 48. India Immune Check Point Inhibitor Sales Market Share by Application in 2019
Figure 49. Advaxis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Agenus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Faron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Genocea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Incyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Innate Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. MacroGenics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. NewLink Genetics Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. TG Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Immune Check Point Inhibitor
Figure 66. Manufacturing Process Analysis of Immune Check Point Inhibitor
Figure 67. Immune Check Point Inhibitor Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
免疫チェックポイント阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Immune Check Point Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Immune Check Poi…- サイトカイン阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Cytokine Inhibitor Market The global Cytokine Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cytokine Inhibitor Scope and Market Size The global Cytokine In…
- B細胞阻害剤の世界市場レポート2020 Market Analysis and Insights: Global B-Cell Inhibitor Market The global B-Cell Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global B-Cell Inhibitor Scope and Market Size The global B-Cell Inhibitor …
- サイトカイン阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cytokine Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cytokine Inhibitor market …
- イミダゾリン誘導体阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Imidazoline Derivative Inhibitor Market The global Imidazoline Derivative Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Imidazoline Derivative Inhibitor Sc…